Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List
| Dataset | w1a_vs_wt_vs_wt.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp_repos |
| Phenotype | w1a_vs_wt.cls#ago1w1a_versus_ago1gfp_repos |
| Upregulated in class | ago1w1a |
| GeneSet | HALLMARK_ALLOGRAFT_REJECTION |
| Enrichment Score (ES) | 0.41764998 |
| Normalized Enrichment Score (NES) | 1.6742249 |
| Nominal p-value | 0.0 |
| FDR q-value | 0.005304918 |
| FWER p-Value | 0.042 |
| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | CCL5 | NA | CCL5 Entrez, Source | chemokine (C-C motif) ligand 5 | 6 | 4.768 | 0.0390 | Yes |
| 2 | IL6 | NA | IL6 Entrez, Source | interleukin 6 (interferon, beta 2) | 17 | 4.596 | 0.0763 | Yes |
| 3 | WARS | NA | WARS Entrez, Source | tryptophanyl-tRNA synthetase | 49 | 4.108 | 0.1084 | Yes |
| 4 | IL2RG | NA | IL2RG Entrez, Source | interleukin 2 receptor, gamma (severe combined immunodeficiency) | 57 | 3.955 | 0.1406 | Yes |
| 5 | CTSS | NA | CTSS Entrez, Source | cathepsin S | 121 | 3.003 | 0.1619 | Yes |
| 6 | IL12RB1 | NA | IL12RB1 Entrez, Source | interleukin 12 receptor, beta 1 | 178 | 2.509 | 0.1795 | Yes |
| 7 | TLR3 | NA | TLR3 Entrez, Source | toll-like receptor 3 | 190 | 2.443 | 0.1990 | Yes |
| 8 | JAK2 | NA | JAK2 Entrez, Source | Janus kinase 2 (a protein tyrosine kinase) | 306 | 1.958 | 0.2087 | Yes |
| 9 | TAP1 | NA | TAP1 Entrez, Source | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 315 | 1.921 | 0.2241 | Yes |
| 10 | FLNA | NA | FLNA Entrez, Source | filamin A, alpha (actin binding protein 280) | 410 | 1.695 | 0.2328 | Yes |
| 11 | IL27RA | NA | IL27RA Entrez, Source | interleukin 27 receptor, alpha | 414 | 1.685 | 0.2466 | Yes |
| 12 | ICAM1 | NA | ICAM1 Entrez, Source | intercellular adhesion molecule 1 (CD54), human rhinovirus receptor | 453 | 1.600 | 0.2576 | Yes |
| 13 | PSMB10 | NA | PSMB10 Entrez, Source | proteasome (prosome, macropain) subunit, beta type, 10 | 480 | 1.569 | 0.2691 | Yes |
| 14 | CCL2 | NA | CCL2 Entrez, Source | chemokine (C-C motif) ligand 2 | 493 | 1.546 | 0.2812 | Yes |
| 15 | IL4R | NA | IL4R Entrez, Source | interleukin 4 receptor | 547 | 1.486 | 0.2905 | Yes |
| 16 | EREG | NA | EREG Entrez, Source | epiregulin | 553 | 1.479 | 0.3024 | Yes |
| 17 | TGFB2 | NA | TGFB2 Entrez, Source | transforming growth factor, beta 2 | 589 | 1.429 | 0.3123 | Yes |
| 18 | TGFB1 | NA | TGFB1 Entrez, Source | transforming growth factor, beta 1 (Camurati-Engelmann disease) | 593 | 1.425 | 0.3238 | Yes |
| 19 | TAPBP | NA | TAPBP Entrez, Source | TAP binding protein (tapasin) | 717 | 1.313 | 0.3278 | Yes |
| 20 | IL1B | NA | IL1B Entrez, Source | interleukin 1, beta | 779 | 1.262 | 0.3348 | Yes |
| 21 | IL7 | NA | IL7 Entrez, Source | interleukin 7 | 857 | 1.205 | 0.3405 | Yes |
| 22 | BCL10 | NA | BCL10 Entrez, Source | B-cell CLL/lymphoma 10 | 1035 | 1.099 | 0.3397 | Yes |
| 23 | EGFR | NA | EGFR Entrez, Source | epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) | 1042 | 1.098 | 0.3484 | Yes |
| 24 | TNF | NA | TNF Entrez, Source | tumor necrosis factor (TNF superfamily, member 2) | 1210 | 1.015 | 0.3475 | Yes |
| 25 | BCL3 | NA | BCL3 Entrez, Source | B-cell CLL/lymphoma 3 | 1300 | 0.982 | 0.3506 | Yes |
| 26 | CCND3 | NA | CCND3 Entrez, Source | cyclin D3 | 1347 | 0.964 | 0.3560 | Yes |
| 27 | CD79A | NA | CD79A Entrez, Source | CD79a molecule, immunoglobulin-associated alpha | 1469 | 0.920 | 0.3569 | Yes |
| 28 | RARS | NA | RARS Entrez, Source | arginyl-tRNA synthetase | 1535 | 0.900 | 0.3607 | Yes |
| 29 | FAS | NA | FAS Entrez, Source | Fas (TNF receptor superfamily, member 6) | 1600 | 0.881 | 0.3644 | Yes |
| 30 | IL12B | NA | IL12B Entrez, Source | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 1607 | 0.880 | 0.3713 | Yes |
| 31 | CSF1 | NA | CSF1 Entrez, Source | colony stimulating factor 1 (macrophage) | 1608 | 0.880 | 0.3785 | Yes |
| 32 | HLA-G | NA | HLA-G Entrez, Source | HLA-G histocompatibility antigen, class I, G | 1786 | 0.832 | 0.3755 | Yes |
| 33 | HLA-A | NA | HLA-A Entrez, Source | major histocompatibility complex, class I, A | 1869 | 0.815 | 0.3777 | Yes |
| 34 | ICOSLG | NA | ICOSLG Entrez, Source | inducible T-cell co-stimulator ligand | 1903 | 0.808 | 0.3825 | Yes |
| 35 | IL18 | NA | IL18 Entrez, Source | interleukin 18 (interferon-gamma-inducing factor) | 1911 | 0.805 | 0.3888 | Yes |
| 36 | HLA-E | NA | HLA-E Entrez, Source | major histocompatibility complex, class I, E | 1915 | 0.805 | 0.3952 | Yes |
| 37 | B2M | NA | B2M Entrez, Source | beta-2-microglobulin | 1917 | 0.805 | 0.4018 | Yes |
| 38 | CSK | NA | CSK Entrez, Source | c-src tyrosine kinase | 1991 | 0.790 | 0.4043 | Yes |
| 39 | TAP2 | NA | TAP2 Entrez, Source | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 2093 | 0.768 | 0.4050 | Yes |
| 40 | LIF | NA | LIF Entrez, Source | leukemia inhibitory factor (cholinergic differentiation factor) | 2141 | 0.755 | 0.4086 | Yes |
| 41 | CD47 | NA | CD47 Entrez, Source | CD47 molecule | 2166 | 0.751 | 0.4134 | Yes |
| 42 | PRKCG | NA | PRKCG Entrez, Source | protein kinase C, gamma | 2351 | 0.711 | 0.4091 | Yes |
| 43 | SOCS1 | NA | SOCS1 Entrez, Source | suppressor of cytokine signaling 1 | 2485 | 0.686 | 0.4073 | Yes |
| 44 | NCF4 | NA | NCF4 Entrez, Source | neutrophil cytosolic factor 4, 40kDa | 2512 | 0.682 | 0.4115 | Yes |
| 45 | IL2RA | NA | IL2RA Entrez, Source | interleukin 2 receptor, alpha | 2605 | 0.665 | 0.4119 | Yes |
| 46 | CCL22 | NA | CCL22 Entrez, Source | chemokine (C-C motif) ligand 22 | 2709 | 0.648 | 0.4115 | Yes |
| 47 | IL15 | NA | IL15 Entrez, Source | interleukin 15 | 2774 | 0.635 | 0.4131 | Yes |
| 48 | STAT1 | NA | STAT1 Entrez, Source | signal transducer and activator of transcription 1, 91kDa | 2854 | 0.622 | 0.4139 | Yes |
| 49 | FGR | NA | FGR Entrez, Source | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 2950 | 0.604 | 0.4136 | Yes |
| 50 | IFNAR2 | NA | IFNAR2 Entrez, Source | interferon (alpha, beta and omega) receptor 2 | 3113 | 0.580 | 0.4093 | Yes |
| 51 | HLA-DOB | NA | HLA-DOB Entrez, Source | major histocompatibility complex, class II, DO beta | 3137 | 0.577 | 0.4128 | Yes |
| 52 | IFNGR1 | NA | IFNGR1 Entrez, Source | interferon gamma receptor 1 | 3151 | 0.575 | 0.4168 | Yes |
| 53 | TRAF2 | NA | TRAF2 Entrez, Source | TNF receptor-associated factor 2 | 3221 | 0.564 | 0.4176 | Yes |
| 54 | ETS1 | NA | ETS1 Entrez, Source | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 3360 | 0.542 | 0.4144 | No |
| 55 | CAPG | NA | CAPG Entrez, Source | capping protein (actin filament), gelsolin-like | 3409 | 0.535 | 0.4162 | No |
| 56 | TIMP1 | NA | TIMP1 Entrez, Source | TIMP metallopeptidase inhibitor 1 | 3797 | 0.486 | 0.3987 | No |
| 57 | CARTPT | NA | CARTPT Entrez, Source | CART prepropeptide | 3808 | 0.484 | 0.4021 | No |
| 58 | INHBB | NA | INHBB Entrez, Source | inhibin, beta B (activin AB beta polypeptide) | 3838 | 0.482 | 0.4044 | No |
| 59 | TLR6 | NA | TLR6 Entrez, Source | toll-like receptor 6 | 3957 | 0.467 | 0.4017 | No |
| 60 | DEGS1 | NA | DEGS1 Entrez, Source | degenerative spermatocyte homolog 1, lipid desaturase (Drosophila) | 4047 | 0.455 | 0.4005 | No |
| 61 | PTPRC | NA | PTPRC Entrez, Source | protein tyrosine phosphatase, receptor type, C | 4219 | 0.432 | 0.3946 | No |
| 62 | LYN | NA | LYN Entrez, Source | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 4244 | 0.428 | 0.3968 | No |
| 63 | UBE2D1 | NA | UBE2D1 Entrez, Source | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 4277 | 0.425 | 0.3985 | No |
| 64 | ELF4 | NA | ELF4 Entrez, Source | E74-like factor 4 (ets domain transcription factor) | 4313 | 0.421 | 0.4000 | No |
| 65 | GLMN | NA | GLMN Entrez, Source | glomulin, FKBP associated protein | 4323 | 0.420 | 0.4030 | No |
| 66 | IL11 | NA | IL11 Entrez, Source | interleukin 11 | 4400 | 0.411 | 0.4021 | No |
| 67 | CCR5 | NA | CCR5 Entrez, Source | chemokine (C-C motif) receptor 5 | 4520 | 0.400 | 0.3988 | No |
| 68 | LY86 | NA | LY86 Entrez, Source | lymphocyte antigen 86 | 4639 | 0.388 | 0.3954 | No |
| 69 | TLR2 | NA | TLR2 Entrez, Source | toll-like receptor 2 | 4677 | 0.385 | 0.3966 | No |
| 70 | APBB1 | NA | APBB1 Entrez, Source | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 4943 | 0.356 | 0.3848 | No |
| 71 | C2 | NA | C2 Entrez, Source | complement component 2 | 5139 | 0.338 | 0.3767 | No |
| 72 | MAP4K1 | NA | MAP4K1 Entrez, Source | mitogen-activated protein kinase kinase kinase kinase 1 | 5184 | 0.333 | 0.3770 | No |
| 73 | CD74 | NA | CD74 Entrez, Source | CD74 molecule, major histocompatibility complex, class II invariant chain | 5187 | 0.333 | 0.3796 | No |
| 74 | DYRK3 | NA | DYRK3 Entrez, Source | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 | 5329 | 0.320 | 0.3744 | No |
| 75 | CD3E | NA | CD3E Entrez, Source | CD3e molecule, epsilon (CD3-TCR complex) | 5531 | 0.301 | 0.3657 | No |
| 76 | CD40LG | NA | CD40LG Entrez, Source | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) | 5545 | 0.300 | 0.3675 | No |
| 77 | SOCS5 | NA | SOCS5 Entrez, Source | suppressor of cytokine signaling 5 | 6031 | 0.261 | 0.3426 | No |
| 78 | MTIF2 | NA | MTIF2 Entrez, Source | mitochondrial translational initiation factor 2 | 6199 | 0.245 | 0.3354 | No |
| 79 | CCL11 | NA | CCL11 Entrez, Source | chemokine (C-C motif) ligand 11 | 6398 | 0.228 | 0.3262 | No |
| 80 | BRCA1 | NA | BRCA1 Entrez, Source | breast cancer 1, early onset | 6475 | 0.223 | 0.3238 | No |
| 81 | EIF5A | NA | EIF5A Entrez, Source | eukaryotic translation initiation factor 5A | 6519 | 0.219 | 0.3232 | No |
| 82 | LCK | NA | LCK Entrez, Source | lymphocyte-specific protein tyrosine kinase | 6635 | 0.208 | 0.3186 | No |
| 83 | CCR2 | NA | CCR2 Entrez, Source | chemokine (C-C motif) receptor 2 | 6641 | 0.207 | 0.3200 | No |
| 84 | ABI1 | NA | ABI1 Entrez, Source | abl-interactor 1 | 6739 | 0.201 | 0.3163 | No |
| 85 | RIPK2 | NA | RIPK2 Entrez, Source | receptor-interacting serine-threonine kinase 2 | 6804 | 0.196 | 0.3143 | No |
| 86 | SIT1 | NA | SIT1 Entrez, Source | signaling threshold regulating transmembrane adaptor 1 | 6869 | 0.190 | 0.3123 | No |
| 87 | HDAC9 | NA | HDAC9 Entrez, Source | histone deacetylase 9 | 6990 | 0.181 | 0.3071 | No |
| 88 | IFNGR2 | NA | IFNGR2 Entrez, Source | interferon gamma receptor 2 (interferon gamma transducer 1) | 7118 | 0.172 | 0.3015 | No |
| 89 | HIF1A | NA | HIF1A Entrez, Source | hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7212 | 0.166 | 0.2977 | No |
| 90 | KRT1 | NA | KRT1 Entrez, Source | keratin 1 (epidermolytic hyperkeratosis) | 7232 | 0.165 | 0.2980 | No |
| 91 | IL2 | NA | IL2 Entrez, Source | interleukin 2 | 7269 | 0.162 | 0.2973 | No |
| 92 | ACHE | NA | ACHE Entrez, Source | acetylcholinesterase (Yt blood group) | 7305 | 0.159 | 0.2967 | No |
| 93 | INHBA | NA | INHBA Entrez, Source | inhibin, beta A (activin A, activin AB alpha polypeptide) | 7309 | 0.159 | 0.2978 | No |
| 94 | ACVR2A | NA | ACVR2A Entrez, Source | activin A receptor, type IIA | 7365 | 0.155 | 0.2960 | No |
| 95 | STAT4 | NA | STAT4 Entrez, Source | signal transducer and activator of transcription 4 | 7424 | 0.150 | 0.2940 | No |
| 96 | IL13 | NA | IL13 Entrez, Source | interleukin 13 | 7770 | 0.125 | 0.2759 | No |
| 97 | CXCL13 | NA | CXCL13 Entrez, Source | chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) | 7849 | 0.119 | 0.2725 | No |
| 98 | NLRP3 | NA | 7867 | 0.117 | 0.2725 | No | ||
| 99 | CD8B | NA | CD8B Entrez, Source | CD8b molecule | 7882 | 0.117 | 0.2727 | No |
| 100 | AKT1 | NA | AKT1 Entrez, Source | v-akt murine thymoma viral oncogene homolog 1 | 7922 | 0.113 | 0.2715 | No |
| 101 | ELANE | NA | 8171 | 0.095 | 0.2584 | No | ||
| 102 | LTB | NA | LTB Entrez, Source | lymphotoxin beta (TNF superfamily, member 3) | 8197 | 0.093 | 0.2578 | No |
| 103 | CCL7 | NA | CCL7 Entrez, Source | chemokine (C-C motif) ligand 7 | 8211 | 0.092 | 0.2579 | No |
| 104 | PF4 | NA | PF4 Entrez, Source | platelet factor 4 (chemokine (C-X-C motif) ligand 4) | 8263 | 0.089 | 0.2558 | No |
| 105 | KLRD1 | NA | KLRD1 Entrez, Source | killer cell lectin-like receptor subfamily D, member 1 | 8851 | 0.047 | 0.2235 | No |
| 106 | TLR1 | NA | TLR1 Entrez, Source | toll-like receptor 1 | 8972 | 0.037 | 0.2171 | No |
| 107 | RPS9 | NA | RPS9 Entrez, Source | ribosomal protein S9 | 9006 | 0.035 | 0.2156 | No |
| 108 | CRTAM | NA | CRTAM Entrez, Source | cytotoxic and regulatory T cell molecule | 9018 | 0.034 | 0.2152 | No |
| 109 | IRF7 | NA | IRF7 Entrez, Source | interferon regulatory factor 7 | 9107 | 0.027 | 0.2106 | No |
| 110 | CD28 | NA | CD28 Entrez, Source | CD28 molecule | 9247 | 0.017 | 0.2030 | No |
| 111 | WAS | NA | WAS Entrez, Source | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 9381 | 0.009 | 0.1956 | No |
| 112 | UBE2N | NA | UBE2N Entrez, Source | ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast) | 9486 | 0.002 | 0.1899 | No |
| 113 | NCK1 | NA | NCK1 Entrez, Source | NCK adaptor protein 1 | 9503 | 0.000 | 0.1890 | No |
| 114 | IL4 | NA | IL4 Entrez, Source | interleukin 4 | 9534 | 0.000 | 0.1873 | No |
| 115 | CD3D | NA | CD3D Entrez, Source | CD3d molecule, delta (CD3-TCR complex) | 9710 | 0.000 | 0.1776 | No |
| 116 | GPR65 | NA | GPR65 Entrez, Source | G protein-coupled receptor 65 | 9725 | -0.000 | 0.1768 | No |
| 117 | CDKN2A | NA | CDKN2A Entrez, Source | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 9855 | -0.010 | 0.1697 | No |
| 118 | GCNT1 | NA | GCNT1 Entrez, Source | glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase) | 9958 | -0.017 | 0.1642 | No |
| 119 | CCND2 | NA | CCND2 Entrez, Source | cyclin D2 | 10056 | -0.023 | 0.1590 | No |
| 120 | RPS19 | NA | RPS19 Entrez, Source | ribosomal protein S19 | 10226 | -0.033 | 0.1498 | No |
| 121 | TRAT1 | NA | TRAT1 Entrez, Source | T cell receptor associated transmembrane adaptor 1 | 10320 | -0.039 | 0.1450 | No |
| 122 | HCLS1 | NA | HCLS1 Entrez, Source | hematopoietic cell-specific Lyn substrate 1 | 10470 | -0.046 | 0.1371 | No |
| 123 | CD1D | NA | CD1D Entrez, Source | CD1d molecule | 10589 | -0.053 | 0.1309 | No |
| 124 | GALNT1 | NA | GALNT1 Entrez, Source | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) | 10612 | -0.055 | 0.1302 | No |
| 125 | PRF1 | NA | PRF1 Entrez, Source | perforin 1 (pore forming protein) | 10618 | -0.055 | 0.1303 | No |
| 126 | EIF3D | NA | 10622 | -0.055 | 0.1306 | No | ||
| 127 | CXCL9 | NA | CXCL9 Entrez, Source | chemokine (C-X-C motif) ligand 9 | 10624 | -0.055 | 0.1310 | No |
| 128 | IL12A | NA | IL12A Entrez, Source | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) | 10711 | -0.061 | 0.1268 | No |
| 129 | CD40 | NA | CD40 Entrez, Source | CD40 molecule, TNF receptor superfamily member 5 | 10873 | -0.070 | 0.1184 | No |
| 130 | IKBKB | NA | IKBKB Entrez, Source | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 10944 | -0.074 | 0.1151 | No |
| 131 | NCR1 | NA | NCR1 Entrez, Source | natural cytotoxicity triggering receptor 1 | 10956 | -0.075 | 0.1151 | No |
| 132 | EIF3J | NA | 11199 | -0.091 | 0.1024 | No | ||
| 133 | LY75 | NA | LY75 Entrez, Source | lymphocyte antigen 75 | 11247 | -0.094 | 0.1005 | No |
| 134 | HLA-DQA1 | NA | HLA-DQA1 Entrez, Source | major histocompatibility complex, class II, DQ alpha 1 | 11431 | -0.108 | 0.0913 | No |
| 135 | CD3G | NA | CD3G Entrez, Source | CD3g molecule, gamma (CD3-TCR complex) | 11473 | -0.113 | 0.0899 | No |
| 136 | SRGN | NA | 11542 | -0.118 | 0.0871 | No | ||
| 137 | MRPL3 | NA | MRPL3 Entrez, Source | mitochondrial ribosomal protein L3 | 11614 | -0.123 | 0.0842 | No |
| 138 | CD8A | NA | CD8A Entrez, Source | CD8a molecule | 11810 | -0.141 | 0.0745 | No |
| 139 | LCP2 | NA | LCP2 Entrez, Source | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 11815 | -0.141 | 0.0754 | No |
| 140 | CD7 | NA | CD7 Entrez, Source | CD7 molecule | 11872 | -0.146 | 0.0735 | No |
| 141 | ABCE1 | NA | ABCE1 Entrez, Source | ATP-binding cassette, sub-family E (OABP), member 1 | 11919 | -0.149 | 0.0722 | No |
| 142 | TPD52 | NA | TPD52 Entrez, Source | tumor protein D52 | 11937 | -0.150 | 0.0725 | No |
| 143 | CD96 | NA | CD96 Entrez, Source | CD96 molecule | 12023 | -0.158 | 0.0690 | No |
| 144 | DARS | NA | DARS Entrez, Source | aspartyl-tRNA synthetase | 12044 | -0.159 | 0.0692 | No |
| 145 | FCGR2B | NA | FCGR2B Entrez, Source | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 12103 | -0.164 | 0.0674 | No |
| 146 | IL2RB | NA | IL2RB Entrez, Source | interleukin 2 receptor, beta | 12478 | -0.199 | 0.0482 | No |
| 147 | NPM1 | NA | NPM1 Entrez, Source | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 12872 | -0.232 | 0.0282 | No |
| 148 | NOS2 | NA | 12973 | -0.243 | 0.0247 | No | ||
| 149 | MMP9 | NA | MMP9 Entrez, Source | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 13001 | -0.245 | 0.0252 | No |
| 150 | RPL3L | NA | RPL3L Entrez, Source | ribosomal protein L3-like | 13298 | -0.272 | 0.0110 | No |
| 151 | CD86 | NA | CD86 Entrez, Source | CD86 molecule | 13386 | -0.280 | 0.0084 | No |
| 152 | CCL19 | NA | CCL19 Entrez, Source | chemokine (C-C motif) ligand 19 | 13652 | -0.307 | -0.0038 | No |
| 153 | IGSF6 | NA | IGSF6 Entrez, Source | immunoglobulin superfamily, member 6 | 13690 | -0.310 | -0.0033 | No |
| 154 | FASLG | NA | FASLG Entrez, Source | Fas ligand (TNF superfamily, member 6) | 13862 | -0.326 | -0.0101 | No |
| 155 | SPI1 | NA | SPI1 Entrez, Source | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 13887 | -0.329 | -0.0087 | No |
| 156 | EIF3A | NA | 13915 | -0.332 | -0.0075 | No | ||
| 157 | MAP3K7 | NA | MAP3K7 Entrez, Source | mitogen-activated protein kinase kinase kinase 7 | 14046 | -0.351 | -0.0118 | No |
| 158 | CFP | NA | CFP Entrez, Source | complement factor properdin | 14067 | -0.354 | -0.0100 | No |
| 159 | CD247 | NA | CD247 Entrez, Source | CD247 molecule | 14094 | -0.357 | -0.0085 | No |
| 160 | IRF8 | NA | IRF8 Entrez, Source | interferon regulatory factor 8 | 14315 | -0.381 | -0.0176 | No |
| 161 | EIF4G3 | NA | EIF4G3 Entrez, Source | eukaryotic translation initiation factor 4 gamma, 3 | 14458 | -0.400 | -0.0222 | No |
| 162 | F2R | NA | F2R Entrez, Source | coagulation factor II (thrombin) receptor | 14494 | -0.404 | -0.0209 | No |
| 163 | RPL9 | NA | RPL9 Entrez, Source | ribosomal protein L9 | 14529 | -0.409 | -0.0194 | No |
| 164 | ITK | NA | ITK Entrez, Source | IL2-inducible T-cell kinase | 14581 | -0.416 | -0.0188 | No |
| 165 | IFNG | NA | IFNG Entrez, Source | interferon, gamma | 14617 | -0.420 | -0.0173 | No |
| 166 | CXCR3 | NA | CXCR3 Entrez, Source | chemokine (C-X-C motif) receptor 3 | 14620 | -0.420 | -0.0139 | No |
| 167 | NME1 | NA | NME1 Entrez, Source | non-metastatic cells 1, protein (NM23A) expressed in | 14686 | -0.429 | -0.0140 | No |
| 168 | IL18RAP | NA | IL18RAP Entrez, Source | interleukin 18 receptor accessory protein | 14782 | -0.443 | -0.0156 | No |
| 169 | F2 | NA | F2 Entrez, Source | coagulation factor II (thrombin) | 14879 | -0.459 | -0.0172 | No |
| 170 | BCAT1 | NA | BCAT1 Entrez, Source | branched chain aminotransferase 1, cytosolic | 14948 | -0.468 | -0.0171 | No |
| 171 | GZMA | NA | GZMA Entrez, Source | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 14995 | -0.474 | -0.0158 | No |
| 172 | HLA-DOA | NA | HLA-DOA Entrez, Source | major histocompatibility complex, class II, DO alpha | 15257 | -0.511 | -0.0261 | No |
| 173 | ZAP70 | NA | ZAP70 Entrez, Source | zeta-chain (TCR) associated protein kinase 70kDa | 15272 | -0.513 | -0.0226 | No |
| 174 | RPS3A | NA | RPS3A Entrez, Source | ribosomal protein S3A | 15343 | -0.522 | -0.0222 | No |
| 175 | ITGAL | NA | ITGAL Entrez, Source | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 15441 | -0.540 | -0.0232 | No |
| 176 | PRKCB | NA | 15489 | -0.550 | -0.0212 | No | ||
| 177 | HLA-DMB | NA | HLA-DMB Entrez, Source | major histocompatibility complex, class II, DM beta | 15525 | -0.556 | -0.0186 | No |
| 178 | THY1 | NA | THY1 Entrez, Source | Thy-1 cell surface antigen | 15540 | -0.559 | -0.0148 | No |
| 179 | RPL39 | NA | RPL39 Entrez, Source | ribosomal protein L39 | 15542 | -0.559 | -0.0102 | No |
| 180 | IL10 | NA | IL10 Entrez, Source | interleukin 10 | 15556 | -0.562 | -0.0063 | No |
| 181 | ST8SIA4 | NA | ST8SIA4 Entrez, Source | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | 15666 | -0.584 | -0.0076 | No |
| 182 | MBL2 | NA | MBL2 Entrez, Source | mannose-binding lectin (protein C) 2, soluble (opsonic defect) | 15678 | -0.586 | -0.0033 | No |
| 183 | AARS | NA | AARS Entrez, Source | alanyl-tRNA synthetase | 15849 | -0.621 | -0.0077 | No |
| 184 | IRF4 | NA | IRF4 Entrez, Source | interferon regulatory factor 4 | 15869 | -0.627 | -0.0036 | No |
| 185 | CD80 | NA | CD80 Entrez, Source | CD80 molecule | 16598 | -0.825 | -0.0373 | No |
| 186 | ITGB2 | NA | ITGB2 Entrez, Source | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 16810 | -0.892 | -0.0417 | No |
| 187 | CD2 | NA | CD2 Entrez, Source | CD2 molecule | 17032 | -0.986 | -0.0458 | No |
| 188 | PTPN6 | NA | PTPN6 Entrez, Source | protein tyrosine phosphatase, non-receptor type 6 | 17170 | -1.045 | -0.0448 | No |
| 189 | IL16 | NA | IL16 Entrez, Source | interleukin 16 (lymphocyte chemoattractant factor) | 17417 | -1.198 | -0.0487 | No |
| 190 | CD4 | NA | CD4 Entrez, Source | CD4 molecule | 17673 | -1.437 | -0.0510 | No |
| 191 | STAB1 | NA | STAB1 Entrez, Source | stabilin 1 | 17747 | -1.533 | -0.0424 | No |
| 192 | CCR1 | NA | CCR1 Entrez, Source | chemokine (C-C motif) receptor 1 | 17913 | -1.895 | -0.0360 | No |
| 193 | HLA-DMA | NA | HLA-DMA Entrez, Source | major histocompatibility complex, class II, DM alpha | 18085 | -2.849 | -0.0220 | No |
| 194 | GBP2 | NA | GBP2 Entrez, Source | guanylate binding protein 2, interferon-inducible | 18111 | -3.218 | 0.0031 | No |
